Yaniv Sneor's guest appearances

Yaniv Sneor

Strategy Sprints

The Compassionate Capitalist Show™ with Karen Rands

Project Medtech Podcast

Medtech Money Podcast

Ray Dalio

David Allen

David Smith

Ladan Jiracek

Nir Eyal

Perry Marshall

Peter Block

Dan Miller

Matthew Pollard

Todd Palmer

Gino Wickman

Alan Donegan

Charlene Li

John Livesay

Michael Zipursky

OwlTail

RECOMMENDED FREE TOOLS 🚀 Increase competitive advantage https://www.strategysprints.com/tools 🌍 Double your sales   https://www.strategysprints.com/tools 👊 Get better clients https://www.strategysprints.com/tools BE MY FRIEND 🌍 My website / blog   https://www.strategysprints.com/articles 📸 Instagram - https://instagram.com/strategysprints 😃 Linkedin - https://linkedin.com/in/simonseverino WHO AM I: I'm Simon Severino, CEO of Strategy Sprints ( https://www.strategysprints.com ) and I write a weekly email newsletter that shares productivity and business growth advice https://bit.ly/30dPYBb. GET IN TOUCH: 😃 If you'd like to talk, I'd love to hear from you: https://instagram.com/strategysprints 🌍 My website / blog https://www.strategysprints.com/articles

RECOMMENDED FREE TOOLS 🚀 Increase competitive advantage <a href="https://www.strategysprints.com/tools" rel="nofollow" target="_blank">https://www.strategysprints.com/tools</a> 🌍 Double your sales <a href="https://www.strategysprints.com/tools" rel="nofollow" target="_blank">https://www.strategysprints.com/tools</a> 👊 Get better clients <a href="https://www.strategysprints.com/tools" rel="nofollow" target="_blank">https://www.strategysprints.com/tools</a> BE MY FRIEND 🌍 My website / blog <a href="https://www.strategysprints.com/articles" rel="nofollow" target="_blank">https://www.strategysprints.com/articles</a> 📸 Instagram - <a href="https://instagram.com/strategysprints" rel="nofollow" target="_blank">https://instagram.com/strategysprints</a> 😃 Linkedin - <a href="https://linkedin.com/in/simonseverino" rel="nofollow" target="_blank">https://linkedin.com/in/simonseverino</a> WHO AM I: I'm Simon Severino, CEO of Strategy Sprints ( <a href="https://www.strategysprints.com" rel="nofollow" target="_blank">https://www.strategysprints.com</a> ) and I write a weekly email newsletter that shares productivity and business growth advice <a href="https://bit.ly/30dPYBb" rel="nofollow" target="_blank">https://bit.ly/30dPYBb</a>. GET IN TOUCH: 😃 If you'd like to talk, I'd love to hear from you: <a href="https://instagram.com/strategysprints" rel="nofollow" target="_blank">https://instagram.com/strategysprints</a> 🌍 My website / blog <a href="https://www.strategysprints.com/articles" rel="nofollow" target="_blank">https://www.strategysprints.com/articles</a>

Continuous Improvement | Yaniv Sneor and Simon Severino LIVE | STRATEGY SPRINTS 170

 In this episode, Giovanni and Yaniv discuss what angel investors look for, the mechanics of the invest group, how and where they invest, managing a cap table, the diagnostic sector and why they aren't investing as much there, and more Yaniv Sneor LinkedIn MABA Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

<ul> <li>In this episode, Giovanni and Yaniv discuss what angel investors look for, the mechanics of the invest group, how and where they invest, managing a cap table, the diagnostic sector and why they aren't investing as much there, and more</li> <li><a href="https://www.linkedin.com/in/yaniv-sneor-5534131/" rel="nofollow" target="_blank">Yaniv Sneor LinkedIn</a></li> <li><a href="https://bioangels.net/" rel="nofollow" target="_blank">MABA Website</a></li> <li><a href="https://www.linkedin.com/in/giovannilauricella/" rel="nofollow" target="_blank">Giovanni Lauricella LinkedIn</a></li> <li><a href="https://www.linkedin.com/company/project-medtech-podcast/?viewAsMember=true" rel="nofollow" target="_blank">Project Medtech LinkedIn</a></li> <li><a href="https://projectmedtech.com/" rel="nofollow" target="_blank">Project Medtech Website</a></li></ul>

Medtech Money --- Episode 11: Yaniv Sneor, Founder at MABA --- U.S. Angel Groups --- The Hard Truth of Their Investment Approach and Why They Differ